Yan Chen
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 47
- Molecular Medicine top 2%
- Pharmaceutical Science top 1%
- Pharmacology top 1%
- Medicinal Plant Pharmacodynamics Research 10
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 43
-
- Extracellular vesicles in disease 25
- RNA Interference and Gene Delivery 19
- Natural product bioactivities and synthesis 10
-
- MicroRNA in disease regulation 16
-
- Advanced Nanomaterials in Catalysis 13
- Journals
- Molecules (9 papers)International Journal of Nanomedicine (9 papers)Biomaterials Science (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yan Chen
158 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 131
- Biomaterials 1.1k
- Molecular Medicine 294
- Pharmaceutical Science 259
- Pharmacology 364
- Biomedical Engineering 1.5k
Countries citing papers authored by Yan Chen
This map shows the geographic impact of Yan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Chen more than expected).
Fields of papers citing papers by Yan Chen
This network shows the impact of papers produced by Yan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Chen. The network helps show where Yan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 13 | |
| 14 | 2023 | 31 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 8 | |
| 17 | 2021 | 15 | |
| 18 | 2021 | 18 | |
| 19 | Effects of Hederagenin in Suppressing Epithelial-mesenchymal Transition and Invasion of Colon Cancer Cells SW480 | 2016 | 1 |
| 20 | 2008 | 33 |
About Yan Chen
Yan Chen is a scholar working on Biomaterials, Pharmacology, Cancer Research, Complementary and alternative medicine and Pharmaceutical Science, having authored 164 papers that have together received 4.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (47 papers), Nanoplatforms for cancer theranostics (43 papers), Extracellular vesicles in disease (25 papers), RNA Interference and Gene Delivery (19 papers), MicroRNA in disease regulation (16 papers), Advanced Nanomaterials in Catalysis (13 papers), Natural product bioactivities and synthesis (10 papers) and Medicinal Plant Pharmacodynamics Research (10 papers). The work is most often cited by research in Biomaterials (1.1k citations), Molecular Medicine (294 citations), Pharmaceutical Science (259 citations), Pharmacology (364 citations) and Biomedical Engineering (1.5k citations). Yan Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ding Qu, Congyan Liu, Kelong Ai, Lehui Lu, Guangya Xiang, Yao Lu, Jianhua Liu, Yuping Liu, Ling Yuan and Robert J. Lee. Their work appears in journals such as Molecules, International Journal of Nanomedicine, Biomaterials Science, Journal of Ethnopharmacology and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.